Raleigh biotech startup Arrevus gets FDA support for its drug treating cystic fibrosis patients
RALEIGH — Cystic fibrosis (CF) is a heredity disease with no cure. However, Raleigh biotech startup Arrevus believes it owns a drug that...
Organ Care System Used at Florida Hospital Expected to Make More Lungs Suitable for Transplant
Tampa General Hospital (TGH) announced that is the first in Florida to use an organ care system that allows donor lungs, hearts, and...
Creating Intestinal Organoids In Vitro
Scientists in Boston say they have developed a new method for generating groups of intestinal cells that can be used, among others, to...
CF Carriers at Increased Risk for Disease-related Conditions, Study Reports
Cystic fibrosis carriers — individuals who have certain genetic mutations in one of the copies of the CFTR gene — have a significantly...
SIMPLE TREATMENT OF TYPE 2 DIABETES WITH A LOW-CALORIE DIET IS SO EFFECTIVE THAT IT REVERSES THE DIS
A “revolutionary” treatment plan for type 2 diabetes has made the British National Health Service (NHS) very active as they position...
5 FDA approval decisions to watch in the 1st quarter
Credit: Yujin Kim / MedTech Dive, original photo courtesy of U.S. Food and Drug Administration The Food and Drug Administration cleared...